$5.80
1.75% today
Nasdaq, Nov 12, 05:50 pm CET
ISIN
US20451W1018
Symbol
CMPS

Compass Pathways Plc - ADR Stock price

$5.70
-0.59 9.38% 1M
+1.79 45.78% 6M
+1.92 50.79% YTD
+0.39 7.34% 1Y
-5.36 48.46% 3Y
-30.10 84.08% 5Y
-11.30 66.47% 10Y
-11.30 66.47% 20Y
Nasdaq, Closing price Tue, Nov 11 2025
-0.04 0.70%
ISIN
US20451W1018
Symbol
CMPS
Industry

Key metrics

Basic
Market capitalization
$551.1m
Enterprise Value
$396.4m
Net debt
positive
Cash
$185.9m
Shares outstanding
96.0m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
negative
P/B
14.7
Financial Health
Equity Ratio
72.4%
Return on Equity
-100.3%
ROCE
-312.1%
ROIC
180.4%
Debt/Equity
0.8
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-181.2m | $-178.8m
EBIT
$-181.5m | $-182.7m
Net Income
$-237.3m | $-144.7m
Free Cash Flow
$-161.6m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
-7.9% | -0.5%
EBIT
-8.0% | -2.5%
Net Income
-64.0% | 6.8%
Free Cash Flow
-54.3%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-2.5
FCF per Share
$-1.7
Short interest
5.8%
Employees
166
Rev per Employee
$0.0
Show more

Is Compass Pathways Plc - ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,033 stocks worldwide.

Compass Pathways Plc - ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Compass Pathways Plc - ADR forecast:

14x Buy
88%
2x Hold
13%

Analyst Opinions

16 Analysts have issued a Compass Pathways Plc - ADR forecast:

Buy
88%
Hold
13%

Financial data from Compass Pathways Plc - ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 61 61
13% 13%
-
- Research and Development Expense 121 121
6% 6%
-
-181 -181
8% 8%
-
- Depreciation and Amortization 0.26 0.26
225% 225%
-
EBIT (Operating Income) EBIT -181 -181
8% 8%
-
Net Profit -237 -237
64% 64%
-

In millions USD.

Don't miss a Thing! We will send you all news about Compass Pathways Plc - ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Compass Pathways Plc - ADR Stock News

Neutral
Business Wire
7 days ago
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in the Stifel 2025 Healthcare Conference in New York, NY at 10:40 am ET on Tuesday, November 11, 2025. A live audio webcast of these events will...
Neutral
Seeking Alpha
8 days ago
COMPASS Pathways plc ( CMPS ) Q3 2025 Earnings Call November 4, 2025 8:00 AM EST Company Participants Stephen Schultz - Senior Vice President of Investor Relations Kabir Nath - CEO & Director Teri Loxam - CFO, Principal Financial Officer & Principal Accounting Officer Lori Englebert - Chief Commercial Officer Steve Levine - Chief Patient Officer Conference Call Participants Joshua Schimmer - Ca...
Positive
Reuters
8 days ago
Drug developer Compass Pathways said on Tuesday it is pulling forward the expected launch timing of its experimental psilocybin-based depression therapy by 9 to 12 months.
More Compass Pathways Plc - ADR News

Company Profile

Head office United Kingdom
CEO Kabir Nath
Employees 166
Founded 2016
Website compasspathways.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today